Amgen Inc at Citi BioPharma Conference Transcript

Sep 07, 2022 / 12:50PM GMT
Ana BitetoGarg -

Well, good morning, everyone, and thank you for taking the time to join Citi's Annual Biopharma Conference. My name is Ana BitetoGarg. I'm one of the biotech analysts here at Citi. I'm very pleased to be joined for our next fireside chat by the management team from Amgen. So we have the company's CFO, Peter Griffith and we also have the company's Head of R&D, David Reese as well. And before we get into the discussion, if anybody does have any Q&A that you would like to ask, there may be an opportunity to do that towards the end. And with that, I want to thank both of you for being here. And I'll turn it over to you if you want to make any opening.

Peter H. Griffith - Amgen Inc. - Executive VP & CFO

Well, thank you, Nina. Great to see everybody in person. When we got in last night, we didn't quite know what the water was being from California. So it was nice to see a little bit of rain and get a little bit of cool weather it's been quite hot in California. So delighted to be here. And we'd like to thank Citi and we'd like to thank you for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot